CHANCE: Short-Term Antiplatelet Combo Beneficial Post StrokeCHANCE: Short-Term Antiplatelet Combo Beneficial Post Stroke

This trial has succeeded where others have failed, possibly because it excluded patients at high risk of bleeding and because dual therapy was started early and continued for only 3 weeks. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news